Discovery & Development
What makes us unique?
CRT offers both discovery and early clinical development capability.
Find out more ›
Scientists & Inventors
Do you have an idea?
CRT has more than 20 years experience in developing and commercialising technology.
Find out more ›
Institutes & Charities
Looking for a partner?
Personalised services to reflect your requirements and progress your research.
Find out more ›
Research Tools
For further information about antibodies, mouse models and cell lines from CRT or to discuss sales or licensing options, please contact us:
Call +44 (0) 20 7269 3640 Email reagents@cancertechnology.com Please read our disclaimer information View Research toolsSubscribe to our newsletter
Licensing Portfolio
Cancer Research Technology has an impressive range of over 200 oncology-focused projects under development and potentially available for licensing.
Search Licensing Portfolio
Featured Opportunities
News
CRT & Bayer Schering investigate new therapeutic approach in gynaecological & oncological diseases
CRT has signed an agreement with Bayer Schering Pharma AG to evaluate new leptin antagonist peptides as potential experimental treatments in the area of gynaecological diseases, including cancer. Read more ›